ImaRx Therapeutics' Unattributed VC - IV Round

ImaRx Therapeutics raised a round of funding on December 09, 2005. Investors include Solstice Capital.

We are a biopharmaceutical company developing and commercializing therapies for vascular disorders. Our research and development efforts are focused on therapies for stroke and other vascular disorder…

Articles about ImaRx Therapeutics' Unattributed VC - IV Round: